Form D — Moonwalk Biosciences, Inc.
0002004362-26-000003 · filed Sep 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $70,249,973
- Total sold
- $59,999,998
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Moonwalk Biosciences, Inc.
- CIK
- 2004362
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 2 TOWER PLACE, 8TH FLOOR
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-540-9709
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexander Aravanis · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Arash Jamshidi · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Chris Dimitropoulos · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Paul Burton · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Justin Valley · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Elaine Cheung · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Stephen Djedjos · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
John Liles · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗